Clinical Trial: A Phase II Study to Evaluate the Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis

U.S., Dec. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07303777) titled 'A Phase II Study to Evaluate the Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis' on Dec. 23.

Brief Summary: This is a multicenter, randomized, double-blind, placebo parallel controlled study to evaluate the preliminary efficacy, safety, and PopPK profile of ABP-745 in patients with ASCVD. Efficacy of ABP-745 in reducing atherosclerotic plaque compared with placebo will be evaluated in participants with ASCVD. The primary efficacy measurement will be assessed at 52W of treatment.

Study Start Date: Feb., 2026

Study Type: INTERVENTIONAL

Condition: Atherosclerosis Cardiovascular Disease ASCVD ASCVD M...